Tag: telehealth

FDA & Product Rules

FDA Warns RonanRx Over American-Made Claims for Compounded GLP-1s

FDA's October 30, 2026 warning letter to RonanRx says a video calling its compounded semaglutide and tirzepatide "American made" and "farm-to-table drugs" was misleading because FDA lists no U.S. maker of the active ingredients. It also cites implied FDA approval and RonanRx-branded labels.

E-commerce 4 Internet Marketers Editorial
Chargebacks & Fraud

GLP-1 Telehealth Sellers Face Patients Told to Check the Dispensing Pharmacy First

USA Today's October 21 guide sends GLP-1 patients to state pharmacy license lookups, PCAB or CCE accreditation checks, and FDA's compounding actions list. An analysis of what telehealth sellers can disclose about the dispensing pharmacy to build trust and limit disputes.

E-commerce 4 Internet Marketers Editorial
Chargebacks & Fraud

Split Descriptors for Telehealth Consult Fees Versus Pharmacy Fulfillment

Telehealth brands that bill consults and pharmacy fulfillment on separate MIDs can reduce statement confusion and chargebacks when checkout copy, refunds, and descriptors stay aligned. FDA GLP-1 telehealth pressure makes clean money flows part of processor survival too.

E-commerce 4 Internet Marketers Editorial